-
05/01/2011
DBV Technologies closes .5 (€19,4) million Series ‘C’ financing round including new investors InnoBio, Lundbeckfond Ventures, Shire plc, and ALTO Invest; as well as existing investors Sofinnova Partners and ALK Abello
-
05/01/2011
Sofinnova Partners announces the promotion of two of its team members:
-
05/01/2011
Sofinnova Parnters annonce la promotion de deux membres de son équipe:
-
05/01/2011
DBV Technologies finalise un 3ème tour de financement de 19,4 millions € afin d’assurer le développement clinique de Viaskin®Peanut, premier traitement d’immunotherapie spécifique par voie épicutanée de l’allergie à l’arachide. InnoBbio, Lundbeckfond Vent
-
18/01/2011
DBV Technologies elects George Horner as nonexecutive Chairman of the Board of Directors to advance the clinical development of VIASKIN® Peanut, the world’s first
-
19/01/2011
OpenERP Offers ERP in the Cloud
-
27/01/2011
Ascendis Pharma (ACP-001)
-
07/02/2011
McPhy Energy signs contract with Enel Group for solid hydrogen storage
-
07/02/2011
McPhy Energy signe un contrat de fourniture de stockage hydrogène avec le groupe Enel
-
02/03/2011
McPhy Energy va fournir un système de stockage d’hydrogène solide à Iwatani Corporation, leader sur le marché japonais de l’hydrogène
-
02/03/2011
McPhy Energy to supply solid hydrogen storage solution to Iwatani Corporation, Japan's market leader
-
02/03/2011
blueKiwi annonce la nomination de Jean-Luc Valente au poste de President Directeur Général
-
02/03/2011
blueKiwi lance sa nouvelle offre modulaire de réseaux sociaux professionnels
-
05/03/2011
Qosmos signe un partenariaT avec TEOCO
-
14/03/2011
Omthera Pharmaceuticals Raises $33.9 Million in Series B Funding
-
14/03/2011
Omthera Pharmaceuticals Initiates Pivotal Phase III EVOLVE Trial for Epanova in Patients with Very High Triglycerides
-
10/03/2011
Taptu updated to version 1.3
-
30/03/2011
DBV Technologies : Hope for peanut allergy sufferers
-
30/03/2011
Addex Initiates Phase IIa Clinical Trial of Dipraglurant-IR in Parkinson's Disease Levodopa-Induced Dyskinesia (PD-LID)
-
18/04/2011
How Taptu aims to solve news overload on iOS and Android
-
26/04/2011
BioAmber Partners with Mitsubishi Chemical in Succinic Acid
-
21/04/2011
Healthcare Brands International (HBI) announces the sale of its wholly owned Swedish subsidiary, Antula Healthcare, the leading independent OTC healthcare company in the Nordic markets
-
04/05/2011
BioAmber Closes USD45 Million Series B to Fund Succinic and Adipic Platforms
-
05/05/2011
Fundraising round beckons for Taptu as it releases Android tablet app
-
11/05/2011
La bulle Internet n'est plus ce qu'elle était
-
10/05/2011
DBV Technologies: Pioneering the safe desensitization of patient suffering from dangerous food allergies
-
17/05/2011
Pfizer's ANTI-TNF-ALPHA NANOBODY (ATN-103) successfully completes a Phase II study and demonstrates clinical proof-of-concept (POC) in patients with RA
-
20/05/2011
Panda aggrave-t-il la position dominante de Google?
-
17/05/2011
Pfizer's ANTI-TNF-ALPHA NANOBODY (ATN-103) successfully completes a Phase II study and demonstrates clinical proof-of-concept (POC) in patients with RA
-
25/05/2011
Google a une vision hégémonique et caricaturale de l'internet européen
-
31/05/2011
SOLUTIONS 30 reprend les activités d’intervention sur site de Maintenance Partner Solutions en France
-
30/05/2011
Peanut allergy patch investigated
-
15/06/2011
Solutions 30 aide l'Europe à passer au numérique
-
22/06/2011
Endotis initiates Phase IIA study of first-in-class neutralizable anticoagulant in open-heart surgery
-
27/06/2011
Ablynx receives EUR 5 million in milestone payment from alzheimer's disease collaboration with Boehringer Ingelheim
-
24/06/2011
Drs. Ben Machielse Joins Omthera Pharmaceuticals, Inc. As Chief Operating Officer
-
11/07/2011
Solvay and Avantium to jointly develop green engineering plastics
-
06/07/2011
SpineVision® raises $5 million
-
06/07/2011
Bristol-Myers Squibb and Innate Pharma Announce Breakthrough Global License Agreement for an Investigational Immuno-Oncology Biologic
-
04/08/2011
Christian S. Schade to Join Omthera Pharmaceuticals as Executive Vice President and Chief Financial Officer
-
05/08/2011
Jeff Kolstad joins Avantium as Chief Scientist to accelerate bioplastics development
-
08/09/2011
Qosmos Closes €19.8 Million Funding Round with DFJ Esprit, FSI and Alven Capital
-
14/09/2011
BioAmber Partners with PTTMCC Biochem for PBS production in Thailand
-
16/09/2011
Plus de 1 00 00 patients ont bénéficié de la technologie auto¬apposante de STENTYS
-
13/09/2011
OpenERP among 20 Hot International Startups You Need To Watch
-
20/09/2011
Gianbeppi Fortis, Pdg de Solutions 30, est l'invité de l'Entreprise Bfm. Il y évoque notamment son parcours, ses motivations, et son activité actuelle de PC30 à Solutions 30.
-
21/09/2011
Stentys termine le recrutement de l'étude APPOSITION III de son stent auto-apposant pour le traitement des crises cardiaques.
-
08/09/2011
Tapform allows developers, publishers and hardware manufacturers to harness the power of the Taptu news-aggregating engine
-
17/10/2011
Hookipa Biotech Closes €7 million Series A Financing Led by Sofinnova Partners
-
14/11/2011
BioAmber Strengthens its Management Team and Board of Directors
-
22/11/2011
UCB acquires Lectus Therapeutics’ key pharmaceutical assets Agreement adds novel ion channel drug discovery and development programmes for CNS indications to UCB’s New Medicines™ research technologies portfolio
-
29/11/2011
NuCana BioMed Secures $10.4 Million Series A Financing to accelerate its ProTide Anti-Cancer Drugs into Clinical Development
-
30/11/2011
Ablynx reports positive Phase I data for ALX-0061 in rheumatoid arthritis
-
06/12/2011
DBV Technologies se félicite de l’arrivée de Mr. David Schilansky en tant que Directeur Administratif et Financier
-
06/12/2011
DBV Technologies proudly welcomes Mr. David Schilansky as its new Chief Financial Officer
-
13/12/2011
Ablynx initiates Phase I study with ALX-0171 for the treatment of respiratory syncytial virus (RSV)
